» Articles » PMID: 36675155

Synapse Dysfunctions in Multiple Sclerosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jan 21
PMID 36675155
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system (CNS) affecting nearly three million humans worldwide. In MS, cells of an auto-reactive immune system invade the brain and cause neuroinflammation. Neuroinflammation triggers a complex, multi-faceted harmful process not only in the white matter but also in the grey matter of the brain. In the grey matter, neuroinflammation causes synapse dysfunctions. Synapse dysfunctions in MS occur early and independent from white matter demyelination and are likely correlates of cognitive and mental symptoms in MS. Disturbed synapse/glia interactions and elevated neuroinflammatory signals play a central role. Glutamatergic excitotoxic synapse damage emerges as a major mechanism. We review synapse/glia communication under normal conditions and summarize how this communication becomes malfunctional during neuroinflammation in MS. We discuss mechanisms of how disturbed glia/synapse communication can lead to synapse dysfunctions, signaling dysbalance, and neurodegeneration in MS.

Citing Articles

Early Synapse-Specific Alterations of Photoreceptor Mitochondria in the EAE Mouse Model of Multiple Sclerosis.

Ibrahim D, Schwarz K, Suiwal S, Maragkou S, Schmitz F Cells. 2025; 14(3).

PMID: 39936997 PMC: 11816939. DOI: 10.3390/cells14030206.


Decreased Expression of the EAAT5 Glutamate Transporter at Photoreceptor Synapses in Early, Pre-Clinical Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis.

El Samad A, Jaffal J, Ibrahim D, Schwarz K, Schmitz F Biomedicines. 2024; 12(11).

PMID: 39595111 PMC: 11591696. DOI: 10.3390/biomedicines12112545.


Interaction between miR-142-3p and Val/Met Polymorphism Regulates Multiple Sclerosis Severity.

Dolcetti E, Musella A, Balletta S, Gilio L, Bruno A, Stampanoni Bassi M Int J Mol Sci. 2024; 25(10).

PMID: 38791290 PMC: 11121620. DOI: 10.3390/ijms25105253.


Pilot Study of the Total and Phosphorylated Tau Proteins in Early-Stage Multiple Sclerosis.

Masiuliene I, Pampuscenko K, Zemgulyte G, Bilskiene D, Borutaite V, Balnyte R Medicina (Kaunas). 2024; 60(3).

PMID: 38541142 PMC: 10971950. DOI: 10.3390/medicina60030416.


Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720.

Roggeri A, Olivero G, Usai C, Vanmierlo T, Pittaluga A Cells. 2023; 12(19).

PMID: 37830557 PMC: 10571862. DOI: 10.3390/cells12192343.


References
1.
Eyo U, Peng J, Swiatkowski P, Mukherjee A, Bispo A, Wu L . Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. J Neurosci. 2014; 34(32):10528-40. PMC: 4200107. DOI: 10.1523/JNEUROSCI.0416-14.2014. View

2.
Lalo U, Palygin O, Verkhratsky A, Grant S, Pankratov Y . ATP from synaptic terminals and astrocytes regulates NMDA receptors and synaptic plasticity through PSD-95 multi-protein complex. Sci Rep. 2016; 6:33609. PMC: 5027525. DOI: 10.1038/srep33609. View

3.
Michailidou I, Willems J, Kooi E, van Eden C, Gold S, Geurts J . Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann Neurol. 2015; 77(6):1007-26. DOI: 10.1002/ana.24398. View

4.
Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

5.
Ghasemi N, Razavi S, Nikzad E . Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J. 2017; 19(1):1-10. PMC: 5241505. DOI: 10.22074/cellj.2016.4867. View